US 12018027
Macrocyclic derivatives acting as XIa factor inhibitor
granted A61PA61P7/02A61P9/10
Quick answer
US patent 12018027 (Macrocyclic derivatives acting as XIa factor inhibitor) held by China Resources Biopharmaceutical Company Limited expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- China Resources Biopharmaceutical Company Limited
- Grant date
- Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P7/02, A61P9/10